Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214

Switzerland becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 booster vaccineStudy results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and …